Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 1
Neurology Minute · American Academy of Neurology
July 24, 20243m 18s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Efgartigimod and Rozanolixizumab.
Show references:
https://doi.org/10.1016/s1474-4422(21)00159-9
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract